摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-<2-<2-furanylmethylthio>ethanamino>-5-<2-methoxypyrid-4-ylmethyl>-4-pyrimidone | 92838-84-1

中文名称
——
中文别名
——
英文名称
2-<2-<2-furanylmethylthio>ethanamino>-5-<2-methoxypyrid-4-ylmethyl>-4-pyrimidone
英文别名
2-[2-(furan-2-ylmethylsulfanyl)ethylamino]-5-[(2-methoxypyridin-4-yl)methyl]-1H-pyrimidin-6-one
2-<2-<2-furanylmethylthio>ethanamino>-5-<2-methoxypyrid-4-ylmethyl>-4-pyrimidone化学式
CAS
92838-84-1
化学式
C18H20N4O3S
mdl
——
分子量
372.448
InChiKey
ARQYSGDCJSEYAH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.33±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    26
  • 可旋转键数:
    9
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.28
  • 拓扑面积:
    114
  • 氢给体数:
    2
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Isocytosine H2-receptor histamine antagonists. IV. The synthesis and biological activity of donetidine (SK&F 93574) and related compounds
    摘要:
    The synthesis and biological activity of some novel 2-amino-4-pyrimidone derivatives is described. Side-chains associated with H-2-antagonist activity am attached through the 2-amino group, whilst a range of 2-hydroxypyridine containing moieties are substituted at the 5-position of the pyrimidone ring. Good H-2-receptor histamine antagonist activity is observed with all the series and the majority of the compounds are selective for the H-2-receptor. High aqueous solubility and iv potency coupled with an extended duration of biological activity in animal models led to compound 16c, 2-[2-(5-dimethylaminomethyl-2-furanylmethyl-thio)ethylamino]-5-(2-hydroxypyrid-4-ylmethyl)-4-pyrimidone (donetidine, SK&F 93574) being selected for clinical investigation as a potential parenterally administered therapeutic agent.
    DOI:
    10.1016/0223-5234(93)90091-r
  • 作为产物:
    描述:
    4-氰基-2-甲氧基吡啶 在 palladium on activated charcoal 、 哌啶吡啶盐酸聚合甲醛氢气sodium methylate盐酸氨基脲sodium acetate 、 sodium hydride 作用下, 以 甲醇乙二醇二甲醚乙醇 为溶剂, 反应 62.5h, 生成 2-<2-<2-furanylmethylthio>ethanamino>-5-<2-methoxypyrid-4-ylmethyl>-4-pyrimidone
    参考文献:
    名称:
    Isocytosine H2-receptor histamine antagonists. IV. The synthesis and biological activity of donetidine (SK&F 93574) and related compounds
    摘要:
    The synthesis and biological activity of some novel 2-amino-4-pyrimidone derivatives is described. Side-chains associated with H-2-antagonist activity am attached through the 2-amino group, whilst a range of 2-hydroxypyridine containing moieties are substituted at the 5-position of the pyrimidone ring. Good H-2-receptor histamine antagonist activity is observed with all the series and the majority of the compounds are selective for the H-2-receptor. High aqueous solubility and iv potency coupled with an extended duration of biological activity in animal models led to compound 16c, 2-[2-(5-dimethylaminomethyl-2-furanylmethyl-thio)ethylamino]-5-(2-hydroxypyrid-4-ylmethyl)-4-pyrimidone (donetidine, SK&F 93574) being selected for clinical investigation as a potential parenterally administered therapeutic agent.
    DOI:
    10.1016/0223-5234(93)90091-r
点击查看最新优质反应信息

文献信息

  • Chemical process for preparing H2-antagonists
    申请人:SMITH KLINE & FRENCH LABORATORIES LIMITED
    公开号:EP0112637A2
    公开(公告)日:1984-07-04
    A chemical process is described for the preparation of H2-antagonists or precursors thereof, of the formula (V): wherein R' is 5-methylimidazol-4-yl, furan-2-yl or 5-dimeth- ylaminomethylfuran-2-yl and R2 is 3,4-methylenedioxyphenyl or optionally protected 2-hydroxypyrid-4-yl; which process comprises reacting a compound of the formula (VI) with a compound of the formula (VII): wherein R3 is C1-6alkyl; and thereafter if desired deprotecting a protected hydroxy group, converting a compound wherein R1 is furan-2-yl into a compound wherein R1 is 5-di- methylaminomethylfuran-2-yl, and/or forming a pharmaceutically acceptable salt.
    描述了一种制备式(V)的 H2-拮抗剂或其前体的化学工艺: 其中 R'为 5-甲基咪唑-4-基、呋喃-2-基或 5-二甲基氨基甲基呋喃-2-基,R2 为 3,4-亚甲基二氧苯基或经选择保护的 2-羟基吡啶-4-基;该工艺包括使式(VI)化合物与式(VII)化合物反应: 其中 R3 为 C1-6 烷基;然后,如果需要,对受保护的羟基进行脱保护,将 R1 为呋喃-2-基的化合物转化为 R1 为 5-二甲氨基甲基呋喃-2-基的化合物,和/或形成药学上可接受的盐。
  • Chemical process
    申请人:SMITH KLINE & FRENCH LABORATORIES LIMITED
    公开号:EP0141560B1
    公开(公告)日:1989-01-25
  • Isocytosine H2-receptor histamine antagonists. IV. The synthesis and biological activity of donetidine (SK&amp;F 93574) and related compounds
    作者:TH Brown、RC Blakemore、GJ Durant、CR Ganellin、ME Parsons、AC Rasmussen、DA Rawlings
    DOI:10.1016/0223-5234(93)90091-r
    日期:1993.1
    The synthesis and biological activity of some novel 2-amino-4-pyrimidone derivatives is described. Side-chains associated with H-2-antagonist activity am attached through the 2-amino group, whilst a range of 2-hydroxypyridine containing moieties are substituted at the 5-position of the pyrimidone ring. Good H-2-receptor histamine antagonist activity is observed with all the series and the majority of the compounds are selective for the H-2-receptor. High aqueous solubility and iv potency coupled with an extended duration of biological activity in animal models led to compound 16c, 2-[2-(5-dimethylaminomethyl-2-furanylmethyl-thio)ethylamino]-5-(2-hydroxypyrid-4-ylmethyl)-4-pyrimidone (donetidine, SK&F 93574) being selected for clinical investigation as a potential parenterally administered therapeutic agent.
查看更多